FilingIndex
6-KThe Wire

TAKEDA PHARMACEUTICAL CO LTD files 6-K

Filed May 26, 2026 · 1mo ago · Accession 0001395064-26-000156

Plain English

Takeda Pharmaceutical Company Limited is providing an overview of its executive compensation. The filing does not contain financial results or material corporate events.

Read the original on SEC.gov ↗
Filing details
Ticker
TAK
CIK
1395064
Form type
6-K
Filing date
May 26, 2026
Report date
May 26, 2026
Document
form6k_052626x4.htm
Size
5.1 MB